Cargando…
Pharmacological preconditioning with gemfibrozil preserves cardiac function after heart transplantation
While heart transplantation (HTX) is the definitive therapy of heart failure, donor shortage is emerging. Pharmacological activation of soluble guanylate cyclase (sGC) and increased cGMP-signalling have been reported to have cardioprotective properties. Gemfibrozil has recently been shown to exert s...
Autores principales: | Benke, Kálmán, Mátyás, Csaba, Sayour, Alex Ali, Oláh, Attila, Németh, Balázs Tamás, Ruppert, Mihály, Szabó, Gábor, Kökény, Gábor, Horváth, Eszter Mária, Hartyánszky, István, Szabolcs, Zoltán, Merkely, Béla, Radovits, Tamás |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5660179/ https://www.ncbi.nlm.nih.gov/pubmed/29079777 http://dx.doi.org/10.1038/s41598-017-14587-3 |
Ejemplares similares
-
Stimulation of soluble guanylate cyclase improves donor organ function in rat heart transplantation
por: Benke, Kálmán, et al.
Publicado: (2020) -
Characterization of left ventricular myocardial sodium-glucose cotransporter 1 expression in patients with end-stage heart failure
por: Sayour, Alex Ali, et al.
Publicado: (2020) -
Cinaciguat prevents the development of pathologic hypertrophy in a rat model of left ventricular pressure overload
por: Németh, Balázs Tamás, et al.
Publicado: (2016) -
The soluble guanylate cyclase activator cinaciguat prevents cardiac dysfunction in a rat model of type-1 diabetes mellitus
por: Mátyás, Csaba, et al.
Publicado: (2015) -
Prevention of the development of heart failure with preserved ejection fraction by the phosphodiesterase‐5A inhibitor vardenafil in rats with type 2 diabetes
por: Mátyás, Csaba, et al.
Publicado: (2016)